General Information
Gene ID | 8743 |
---|---|
Gene Symbol | TNFSF10 |
Gene Name | tumor necrosis factor (ligand) superfamily, member 10 |
Gene Type | protein-coding |
Cytoband | 3q26 |
Ensembl ID | ENSG00000121858 |
#miR regulators | 17 |
Omim ID | 603598 |
Gene ontology |
GO:0006915: apoptotic process GO:0007165: signal transduction GO:0006919: activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006955: immune response GO:0007267: cell-cell signaling GO:0043065: positive regulation of apoptotic process GO:0043123: positive regulation of I-kappaB kinase/NF-kappaB cascade GO:0043280: positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0090200: positive regulation of release of cytochrome c from mitochondria GO:0097190: apoptotic signaling pathway GO:2001238: positive regulation of extrinsic apoptotic signaling pathway GO:2001239: regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:0005576: extracellular region GO:0005887: integral to plasma membrane GO:0005615: extracellular space GO:0005515: protein binding GO:0005102: receptor binding GO:0005125: cytokine activity GO:0005164: tumor necrosis factor receptor binding GO:0046872: metal ion binding |
KEGG pathways |
4060: Cytokine-cytokine receptor interaction 4210: Apoptosis 4650: Natural killer cell mediated cytotoxicity |
PMID | Title | Tumor | Value |
---|---|---|---|
11992538 | Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. | no | no |
12838325 | Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. | no | no |
12919886 | Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential. | no | no |
15547696 | Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase. | no | no |
16571651 | Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells. | no | no |
17465200 | LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma. | no | no |
20041491 | Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells. | no | no |
21297379 | Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation. | no | no |
22147650 | Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma. | yes | no |
22354724 | Potent growth-inhibitory effect of TRAIL therapy mediated by double-regulated oncolytic adenovirus on osteosarcoma. | no | no |
23145797 | Ether à go-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on osteosarcoma. | no | no |
title | all | all |